Medical marijuana companies in Canada interested in exploring business opportunities overseas are eligible to receive financial aid and other forms of support from the federal government through Canada’s Trade Commissioner Service (TCS).
Matt Lamers
Matt Lamers's Latest Posts
No edibles under New Zealand’s medical cannabis scheme, government says
Businesses will be barred from marketing cannabis edibles under New Zealand’s medical program, which kicks off in April, the government confirmed to Marijuana Business Daily, eliminating for now the opportunity for companies to capitalize on what could be a sizable market.
Thailand issues 442 medical cannabis licenses, but full market access years away, report says
Thailand is on track to be competitive in the nascent Asian medical marijuana and hemp markets, but the full commercialization of the sector and liberal access for private businesses is not likely to be implemented before 2024, according to a new report.
S&P, Toronto Stock Exchange launch cannabis indices
Two indices tracking the performance of cannabis companies on North America’s largest stock exchanges have launched in recent months, demonstrating a growing level of mainstream interest in the burgeoning industry.
Aurora Cannabis offshoot Australis Capital announces CFO departure
Australis Capital, an investment group that spun off from Canada's Aurora Cannabis, announced the departure of Chief Financial Officer Michael Carlotti. In a brief news release issued after market close on Jan. 17, Las Vegas-based Australis...
Aphria One, Brampton subsidiary receive EU-GMP certifications, clearing way for European cannabis exports
Aphria has received its first two essential European quality standard certifications, which the Canadian medical cannabis producer says will allow it to export finished dried flower and oil in bulk to European Union countries with established medical marijuana...
New Zealand to overturn cannabis vaporizer ban, clearing the way for imports
New Zealand plans to reverse a law banning cannabis vaporizers before new regulations kick in for the launch of the country’s medical program in April, Marijuana Business Daily has learned.
Analyst: Most Canadian marijuana firms not ready for next wave of products
The majority of Canadian cannabis companies were not ready for the launch of new cannabis products such as edibles, extracts and topicals, despite having more than a year to prepare for the Cannabis 2.0 era, according to an analyst. Only 10 companies had products...
Ontario Cannabis Store sells out of edibles within hours
Ontario’s only legal online outlet for adult-use cannabis sold out of edibles within hours of their initial availability Thursday, demonstrating exceptionally strong demand in Canada's largest market. Newly regulated Cannabis 2.0 products such as chocolates and vapes...
Cannabis producer Tilray taps ex-Molson, Revlon employees for executive roles
Tilray announced changes to its executive roles this week, appointing former Molson Coors Brewing Co. and Revlon employees to key positions. The British Columbia cannabis producer said Chief Financial Officer Mark Castaneda - on the job for almost two years - would...
Canada’s Aphria reports loss, cuts revenue guidance for 2020
Aphria reported a net loss of 8 million Canadian dollars ($6.2 million) for the second quarter ending Nov. 30, 2019, and the Canadian cannabis producer lowered its fiscal 2020 revenue outlook. The company's net revenue for the three-month period was CA$120.6 million,...
Canopy, Loblaw among 8 hopefuls to take over New Brunswick cannabis sales
An opportunity to exclusively operate New Brunswick’s recreational cannabis retail, wholesale and e-commerce platforms has drawn interest from a wide range of companies, including Canada’s largest food retailer and the biggest marijuana producer in the country.
